BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38841621)

  • 1. Social determinants of health and their relation to suboptimal health status in the context of 3PM: a latent profile analysis.
    Tong LK; Li YY; Liu YB; Zheng MR; Fu GL; Au ML
    EPMA J; 2024 Jun; 15(2):221-232. PubMed ID: 38841621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mediating effect of perceived stress on the relationship between big five personality traits and suboptimal health status in Chinese population: a nationwide survey in the framework of predictive, preventive, and personalized medicine.
    Guan Q; Dong H; Zhang Z; Guo Z; Lin Z; Niu H; Wu Y; Hou H
    EPMA J; 2024 Mar; 15(1):25-38. PubMed ID: 38463623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Region of Portugal.
    Regateiro FJ; Silva H; Lemos MC; Moura G; Torres P; Pereira AD; Dias L; Ferreira PL; Amaral S; Santos MAS
    EPMA J; 2024 Mar; 15(1):135-148. PubMed ID: 38463621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conceptualised psycho-medical footprint for health status outcomes and the potential impacts for early detection and prevention of chronic diseases in the context of 3P medicine.
    Afrifa-Yamoah E; Adua E; Anto EO; Peprah-Yamoah E; Opoku-Yamoah V; Aboagye E; Hashmi R
    EPMA J; 2023 Dec; 14(4):585-599. PubMed ID: 38094584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycomic biomarkers are instrumental for suboptimal health status management in the context of predictive, preventive, and personalized medicine.
    Meng X; Wang B; Xu X; Song M; Hou H; Wang W; Wang Y
    EPMA J; 2022 Jun; 13(2):195-207. PubMed ID: 35719133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint.
    Meng X; Wang F; Gao X; Wang B; Xu X; Wang Y; Wang W; Zeng Q
    EPMA J; 2023 Mar; 14(1):1-20. PubMed ID: 36866157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
    Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
    EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
    Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
    EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a short-form suboptimal health status questionnaire.
    Sun S; Liu H; Guo Z; Guan Q; Wang Y; Wang J; Qi Y; Yan Y; Wang Y; Wen J; Hou H;
    EPMA J; 2023 Dec; 14(4):601-612. PubMed ID: 38094576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social determinants of multimorbidity in Jamaica: application of latent class analysis in a cross-sectional study.
    Craig LS; Cunningham-Myrie CA; Hotchkiss DR; Hernandez JH; Gustat J; Theall KP
    BMC Public Health; 2021 Jun; 21(1):1197. PubMed ID: 34162349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cultural bias in motor function patterns: Potential relevance for predictive, preventive, and personalized medicine.
    Otte K; Ellermeyer T; Suzuki M; Röhling HM; Kuroiwa R; Cooper G; Mansow-Model S; Mori M; Zimmermann H; Brandt AU; Paul F; Hirano S; Kuwabara S; Schmitz-Hübsch T
    EPMA J; 2021 Mar; 12(1):91-101. PubMed ID: 33782636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
    Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
    EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and cost-effectiveness of different breast cancer surgery procedures: a Markov decision tree-based approach in the framework of Predictive, Preventive, and Personalized Medicine.
    Shi HY; Li CH; Chen YC; Chiu CC; Lee HH; Hou MF
    EPMA J; 2023 Sep; 14(3):457-475. PubMed ID: 37605647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting 1-, 3-, 5-, and 8-year all-cause mortality in a community-dwelling older adult cohort: relevance for predictive, preventive, and personalized medicine.
    Chen Y; Deng X; Lin D; Yang P; Wu S; Wang X; Zhou H; Chen X; Wang X; Wu W; Ke K; Huang W; Tan X
    EPMA J; 2023 Dec; 14(4):713-726. PubMed ID: 38094581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual effect of homocysteine and uric acid on arterial stiffness and cardiovascular risk in the context of predictive, preventive, and personalized medicine.
    Wu Z; Zhang H; Li Z; Li H; Miao X; Pan H; Wang J; Liu X; Kang X; Li X; Tao L; Guo X
    EPMA J; 2022 Dec; 13(4):581-595. PubMed ID: 36505895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach.
    Yang J; Ouedraogo SY; Wang J; Li Z; Feng X; Ye Z; Zheng S; Li N; Zhan X
    EPMA J; 2024 Mar; 15(1):67-97. PubMed ID: 38463626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.
    Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
    EPMA J; 2024 Jun; 15(2):149-162. PubMed ID: 38841615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of health status of international migrants and local population in Chile: a population-based, cross-sectional analysis from a social determinants of health perspective.
    Rada I; Oyarte M; Cabieses B
    BMC Public Health; 2022 Jul; 22(1):1329. PubMed ID: 35820866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.